Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

Related Articles by Review for PubMed (Select 11800505)

1.

Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder.

Mohr N, Vythilingum B, Emsley RA, Stein DJ.

Int Clin Psychopharmacol. 2002 Jan;17(1):37-40.

PMID:
11800505
2.

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.

Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF.

Mol Psychiatry. 2006 Jul;11(7):622-32. Epub 2006 Apr 4. Review. Erratum in: Mol Psychiatry. 2006 Aug;11(8):795.

PMID:
16585942
3.

[Efficacy of antipsychotic augmentation therapy in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomised, placebo-controlled trials].

Dold M, Aigner M, Lanzenberger R, Kasper S.

Fortschr Neurol Psychiatr. 2011 Aug;79(8):453-66. doi: 10.1055/s-0031-1273397. Epub 2011 Aug 1. Review. German.

PMID:
21809258
4.

Pharmacological management of obsessive-compulsive disorder: a review for clinicians.

McDonough M, Kennedy N.

Harv Rev Psychiatry. 2002 May-Jun;10(3):127-37. Review.

PMID:
12023928
5.

Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms? A systematic review.

Sareen J, Kirshner A, Lander M, Kjernisted KD, Eleff MK, Reiss JP.

J Affect Disord. 2004 Oct 15;82(2):167-74. Review.

PMID:
15488245
6.

Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials.

Dold M, Aigner M, Lanzenberger R, Kasper S.

Int J Neuropsychopharmacol. 2013 Apr;16(3):557-74. doi: 10.1017/S1461145712000740. Epub 2012 Aug 29. Review.

PMID:
22932229
7.

Antipsychotic treatment in obsessive-compulsive disorder: a literature review.

Keuneman RJ, Pokos V, Weerasundera R, Castle DJ.

Aust N Z J Psychiatry. 2005 May;39(5):336-43. Review.

PMID:
15860020
8.

Issues in the pharmacological treatment of obsessive-compulsive disorder.

Math SB, Janardhan Reddy YC.

Int J Clin Pract. 2007 Jul;61(7):1188-97. Epub 2007 May 18. Review.

PMID:
17511795
9.

The paradox of quetiapine in obsessive-compulsive disorder.

Tranulis C, Potvin S, Gourgue M, Leblanc G, Mancini-Marie A, Stip E.

CNS Spectr. 2005 May;10(5):356-61. Review.

PMID:
15858452
10.

Pharmacological augmentation strategies for treatment-resistant obsessive-compulsive disorder.

Walsh KH, McDougle CJ.

Expert Opin Pharmacother. 2004 Oct;5(10):2059-67. Review.

PMID:
15461541
11.

[Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].

Nakamae T.

Seishin Shinkeigaku Zasshi. 2011;113(10):1016-25. Review. Japanese.

PMID:
22187889
12.

Pharmacotherapies in the management of obsessive-compulsive disorder.

Blier P, Habib R, Flament MF.

Can J Psychiatry. 2006 Jun;51(7):417-30. Review.

PMID:
16838823
13.

The medical treatment of obsessive-compulsive disorder and anxiety.

Bandelow B.

CNS Spectr. 2008 Sep;13(9 Suppl 14):37-46. Review.

PMID:
18849910
14.

Update on pharmacologic management of OCD: agents and augmentation.

McDougle CJ.

J Clin Psychiatry. 1997;58 Suppl 12:11-7. Review.

PMID:
9393391
15.

[Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art].

Kordon A, Zurowski B, Wahl K, Hohagen F.

Nervenarzt. 2011 Mar;82(3):319-20, 322-4. doi: 10.1007/s00115-010-2963-2. Review. German.

PMID:
21340636
16.

A review of pharmacologic treatments for obsessive-compulsive disorder.

Kaplan A, Hollander E.

Psychiatr Serv. 2003 Aug;54(8):1111-8. Review.

PMID:
12883138
17.

Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment.

Poyurovsky M, Weizman A, Weizman R.

CNS Drugs. 2004;18(14):989-1010. Review.

PMID:
15584769
18.

Obsessive-compulsive disorder: a critical review of therapeutic perspectives.

Schruers K, Koning K, Luermans J, Haack MJ, Griez E.

Acta Psychiatr Scand. 2005 Apr;111(4):261-71. Review.

PMID:
15740462
19.

Pharmacological management of treatment-resistant obsessive-compulsive disorder.

Abudy A, Juven-Wetzler A, Zohar J.

CNS Drugs. 2011 Jul;25(7):585-96. doi: 10.2165/11587860-000000000-00000. Review.

PMID:
21699270
20.

Pharmacological treatment of obsessive-compulsive disorder.

Simpson HB.

Curr Top Behav Neurosci. 2010;2:527-43. Review.

PMID:
21309125
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk